Spots Global Cancer Trial Database for Bioequivalency Study of CM082 Tablet in Healthy Volunteers

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Bioequivalency Study of CM082 Tablet in Healthy Volunteers

Official Title: Randomized,Open Label,Two-cycle,Crossover,Single Dose Bioequivalency Study of Two Preparations of CM082 Tablet in Healthy Chinese Volunteers Under Fasted State and After Meal

Study ID: NCT04328506

Conditions

Advanced Malignant Solid Tumors

Interventions

CM082 tablet (test product)

CM082 tablet (reference product)

Study Description

Brief Summary: The main objective of this study is to evaluate the bioequivalency of two preparations of CM082 tablet in Chinese healthy volunteers.

Detailed Description: The main objective of this study is to evaluate the bioequivalency of two preparations of CM082 tablet in Chinese healthy volunteers under fasted state or after meal. In addition, the safety of single dose administration of CM082 tablet in Chinese healthy volunteers will also be evaluated.